| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1050447906 |
| P356 | DOI | 10.1038/SJ.GT.3300878 |
| P698 | PubMed publication ID | 10505109 |
| P5875 | ResearchGate publication ID | 12795566 |
| P2093 | author name string | Ramesh N | |
| Lau S | |||
| Osborne WR | |||
| Wei MQ | |||
| Seppen J | |||
| Lejnieks DV | |||
| P2860 | cites work | T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients | Q45876112 |
| Loss of expression of a retrovirus-transduced gene in human keratinocytes | Q45876919 | ||
| Granulocyte colony-stimulating factor expression from transduced vascular smooth muscle cells provides sustained neutrophil increases in rats | Q45878717 | ||
| Myoblast gene therapy in canine mucopolysaccharidosis. I: Abrogation by an immune response to alpha-L-iduronidase | Q45878952 | ||
| Introduction of vascular smooth muscle cells expressing recombinant genes in vivo | Q67983097 | ||
| Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectors | Q70254245 | ||
| Enhanced expression of fibronectin during in vivo cellular aging of human vascular endothelial cells and skin fibroblasts | Q70680868 | ||
| Long-term secretion of therapeutic proteins from genetically modified skeletal muscles | Q71577331 | ||
| Human gene therapy | Q72882950 | ||
| Cloning and analysis of the promotor region of the human fibronectin gene | Q24614047 | ||
| Fibronectin gene expression in proliferating, quiescent, and SV40-infected mouse kidney cells | Q30984613 | ||
| An alternative approach to somatic cell gene therapy | Q33571138 | ||
| Design of vectors for efficient expression of human purine nucleoside phosphorylase in skin fibroblasts from enzyme-deficient humans | Q33648331 | ||
| Organization of the fibronectin gene provides evidence for exon shuffling during evolution. | Q33929543 | ||
| Gene therapy for long-term expression of erythropoietin in rats | Q34026743 | ||
| Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes | Q34125214 | ||
| Myoblast transfer of human erythropoietin gene in a mouse model of renal failure | Q34210746 | ||
| Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy | Q34319054 | ||
| Correction of lysosomal storage in the liver and spleen of MPS VII mice by implantation of genetically modified skin fibroblasts | Q34352418 | ||
| Continuous systemic secretion of a lysosomal enzyme by genetically modified mouse skin fibroblasts. | Q34353329 | ||
| Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts | Q34421635 | ||
| Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human | Q34597327 | ||
| Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy | Q35064037 | ||
| Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo | Q35123124 | ||
| Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection | Q35687015 | ||
| Human gene therapy comes of age. | Q36220668 | ||
| Internal initiation of translation in retroviral vectors carrying picornavirus 5' nontranslated regions. | Q36797849 | ||
| Long-term expression of human adenosine deaminase in vascular smooth muscle cells of rats: a model for gene therapy | Q36823389 | ||
| Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes | Q37401979 | ||
| Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants | Q37518848 | ||
| Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer | Q37723721 | ||
| High-titer bicistronic retroviral vectors employing foot-and-mouth disease virus internal ribosome entry site | Q39716893 | ||
| The current status of gene therapy using hematopoietic stem cells. | Q40512563 | ||
| E1A-responsive elements for repression of rat fibronectin gene transcription | Q40655173 | ||
| Adeno-associated virus: integration at a specific chromosomal locus | Q40852243 | ||
| The basic science of gene therapy | Q40907463 | ||
| Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vector-corrected fibroblasts secreting high levels of β-glucuronidase | Q41102578 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Long-term expression of a retrovirally introduced beta-galactosidase gene in rodent cells implanted in vivo using biodegradable polymer meshes | Q43511209 | ||
| Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors | Q43716886 | ||
| Long-term delivery of a lysosomal enzyme by genetically modified fibroblasts in dogs | Q44065456 | ||
| Sustainable cutaneous gene delivery | Q44843058 | ||
| Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally transduced smooth muscle cells: a model for local and systemic gene therapy | Q45869992 | ||
| Gene therapy for vascular smooth muscle cell proliferation after arterial injury | Q45871893 | ||
| High-level human adenosine deaminase expression in dog skin fibroblasts is not sustained following transplantation | Q45874914 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 840-844 | |
| P577 | publication date | 1999-05-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Sustained gene expression in transplanted skin fibroblasts in rats | |
| P478 | volume | 6 |
| Q40817567 | Development of disabled, replication-defective gene transfer vectors from the Jembrana disease virus, a new infectious agent of cattle |
| Q33843166 | Gene silencing as a threat to the success of gene therapy |
| Q45862975 | In vivo bone formation in fracture repair induced by direct retroviral-based gene therapy with bone morphogenetic protein-4. |
| Q43954074 | Lentiviral vectors for efficient transduction of isolated primary quiescent hepatocytes |
| Q30885539 | Novel bovine lentiviral vectors based on Jembrana disease virus |
| Q40810564 | VP22 enhanced intercellular trafficking of HSV thymidine kinase reduced the level of ganciclovir needed to cause suicide cell death |
Search more.